Colzyx AB is a biotech company that emphasizes innovative research and development activities to utilize biological modes of action for use in advanced wound management. We envision taking advantage of naturally acting biomechanisms to obtain rapid wound closure, decrease bacterial wound infections and thus accelerate wound healing. The original discovery by the research team behind Colzyx was that Collagen VI, a molecule naturally occurring in all connective tissues, harbors such advanced wound healing properties. In preclinical studies (in vitro and in vivo), Collagen VI, or bioactive peptides derived from Collagen VI, have been confirmed to exert these complementary modes of action.